nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—colon cancer—Crohn's disease	0.628	1	CtDrD
Irinotecan—ALB—Crohn's disease	0.113	1	CbGaD
Irinotecan—SLCO1B1—Sulfasalazine—Crohn's disease	0.0433	0.255	CbGbCtD
Irinotecan—ABCC2—Sulfasalazine—Crohn's disease	0.038	0.224	CbGbCtD
Irinotecan—ABCG2—Sulfasalazine—Crohn's disease	0.0344	0.203	CbGbCtD
Irinotecan—CYP3A5—Sulfasalazine—Crohn's disease	0.0191	0.112	CbGbCtD
Irinotecan—ALB—Prednisone—Crohn's disease	0.019	0.112	CbGbCtD
Irinotecan—ABCB1—Prednisone—Crohn's disease	0.00991	0.0585	CbGbCtD
Irinotecan—CYP3A4—Prednisone—Crohn's disease	0.00594	0.035	CbGbCtD
Irinotecan—ABCC2—bile—Crohn's disease	0.00298	0.144	CbGeAlD
Irinotecan—Frequent bowel movements—Mesalazine—Crohn's disease	0.00186	0.0338	CcSEcCtD
Irinotecan—Colitis ulcerative—Mesalazine—Crohn's disease	0.00174	0.0316	CcSEcCtD
Irinotecan—Proctocolitis—Mesalazine—Crohn's disease	0.00174	0.0316	CcSEcCtD
Irinotecan—Acute leukaemia—Azathioprine—Crohn's disease	0.00168	0.0306	CcSEcCtD
Irinotecan—Lipase increased—Mesalazine—Crohn's disease	0.00149	0.0271	CcSEcCtD
Irinotecan—CES1—gall bladder—Crohn's disease	0.00127	0.0614	CbGeAlD
Irinotecan—Intestinal perforation—Azathioprine—Crohn's disease	0.00122	0.0221	CcSEcCtD
Irinotecan—Lung infiltration—Mesalazine—Crohn's disease	0.000935	0.017	CcSEcCtD
Irinotecan—Rectal disorder—Mesalazine—Crohn's disease	0.000894	0.0163	CcSEcCtD
Irinotecan—ALB—gall bladder—Crohn's disease	0.000883	0.0426	CbGeAlD
Irinotecan—Ulcer—Mercaptopurine—Crohn's disease	0.000854	0.0155	CcSEcCtD
Irinotecan—TOP1—smooth muscle tissue—Crohn's disease	0.000848	0.0409	CbGeAlD
Irinotecan—Anorectal disorder—Mesalazine—Crohn's disease	0.000834	0.0152	CcSEcCtD
Irinotecan—SLC22A3—mouth—Crohn's disease	0.000784	0.0379	CbGeAlD
Irinotecan—CES2—smooth muscle tissue—Crohn's disease	0.000769	0.0371	CbGeAlD
Irinotecan—TOP1—mammalian vulva—Crohn's disease	0.000764	0.0369	CbGeAlD
Irinotecan—CES2—skin of body—Crohn's disease	0.000759	0.0367	CbGeAlD
Irinotecan—UGT1A9—digestive system—Crohn's disease	0.000753	0.0364	CbGeAlD
Irinotecan—Neoplasm—Mercaptopurine—Crohn's disease	0.00073	0.0133	CcSEcCtD
Irinotecan—Enlargement abdomen—Mesalazine—Crohn's disease	0.000729	0.0132	CcSEcCtD
Irinotecan—TOP1MT—lymph node—Crohn's disease	0.000725	0.035	CbGeAlD
Irinotecan—Sepsis—Mercaptopurine—Crohn's disease	0.000701	0.0127	CcSEcCtD
Irinotecan—CES2—mammalian vulva—Crohn's disease	0.000692	0.0334	CbGeAlD
Irinotecan—Hypomagnesaemia—Mesalazine—Crohn's disease	0.00069	0.0125	CcSEcCtD
Irinotecan—Abdominal cramps—Mesalazine—Crohn's disease	0.00065	0.0118	CcSEcCtD
Irinotecan—Intestinal obstruction—Mesalazine—Crohn's disease	0.000643	0.0117	CcSEcCtD
Irinotecan—Thrombosis—Mesalazine—Crohn's disease	0.000619	0.0113	CcSEcCtD
Irinotecan—Lung disorder—Mesalazine—Crohn's disease	0.000619	0.0113	CcSEcCtD
Irinotecan—CES2—digestive system—Crohn's disease	0.000607	0.0293	CbGeAlD
Irinotecan—Neoplasm malignant—Azathioprine—Crohn's disease	0.000564	0.0102	CcSEcCtD
Irinotecan—UGT1A1—digestive system—Crohn's disease	0.000516	0.0249	CbGeAlD
Irinotecan—CES1—lymphoid tissue—Crohn's disease	0.000506	0.0244	CbGeAlD
Irinotecan—CES1—digestive system—Crohn's disease	0.0005	0.0241	CbGeAlD
Irinotecan—Vasodilation procedure—Mesalazine—Crohn's disease	0.000499	0.00907	CcSEcCtD
Irinotecan—Vasodilation—Mesalazine—Crohn's disease	0.000499	0.00907	CcSEcCtD
Irinotecan—Pancreatitis—Mercaptopurine—Crohn's disease	0.000497	0.00903	CcSEcCtD
Irinotecan—Cough increased—Mesalazine—Crohn's disease	0.000479	0.00871	CcSEcCtD
Irinotecan—Blood bilirubin increased—Mesalazine—Crohn's disease	0.000464	0.00843	CcSEcCtD
Irinotecan—Colitis—Azathioprine—Crohn's disease	0.000462	0.0084	CcSEcCtD
Irinotecan—Lymphopenia—Prednisone—Crohn's disease	0.000453	0.00824	CcSEcCtD
Irinotecan—Stomatitis—Mercaptopurine—Crohn's disease	0.000441	0.00801	CcSEcCtD
Irinotecan—SLC22A3—smooth muscle tissue—Crohn's disease	0.00044	0.0212	CbGeAlD
Irinotecan—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000439	0.00797	CcSEcCtD
Irinotecan—Neoplasm—Azathioprine—Crohn's disease	0.000435	0.00791	CcSEcCtD
Irinotecan—SLCO1B1—digestive system—Crohn's disease	0.00043	0.0207	CbGeAlD
Irinotecan—Colitis—Mesalazine—Crohn's disease	0.000421	0.00765	CcSEcCtD
Irinotecan—SLC22A3—mammalian vulva—Crohn's disease	0.000396	0.0191	CbGeAlD
Irinotecan—Febrile neutropenia—Prednisone—Crohn's disease	0.000386	0.00701	CcSEcCtD
Irinotecan—TOP1—lymph node—Crohn's disease	0.000383	0.0185	CbGeAlD
Irinotecan—Immune system disorder—Mercaptopurine—Crohn's disease	0.000366	0.00666	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000366	0.00665	CcSEcCtD
Irinotecan—Embolism—Prednisone—Crohn's disease	0.000361	0.00657	CcSEcCtD
Irinotecan—Alopecia—Mercaptopurine—Crohn's disease	0.000359	0.00652	CcSEcCtD
Irinotecan—CES2—lymph node—Crohn's disease	0.000347	0.0167	CbGeAlD
Irinotecan—Renal failure acute—Mesalazine—Crohn's disease	0.000345	0.00627	CcSEcCtD
Irinotecan—Renal impairment—Mesalazine—Crohn's disease	0.000334	0.00608	CcSEcCtD
Irinotecan—Hepatomegaly—Prednisone—Crohn's disease	0.000328	0.00596	CcSEcCtD
Irinotecan—ABCC1—mammalian vulva—Crohn's disease	0.000327	0.0158	CbGeAlD
Irinotecan—Anaemia—Mercaptopurine—Crohn's disease	0.000326	0.00593	CcSEcCtD
Irinotecan—ABCC2—digestive system—Crohn's disease	0.000326	0.0157	CbGeAlD
Irinotecan—Osteoarthritis—Mesalazine—Crohn's disease	0.000318	0.00579	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000318	0.00579	CcSEcCtD
Irinotecan—Leukopenia—Mercaptopurine—Crohn's disease	0.000316	0.00575	CcSEcCtD
Irinotecan—BCHE—smooth muscle tissue—Crohn's disease	0.000311	0.015	CbGeAlD
Irinotecan—BCHE—skin of body—Crohn's disease	0.000307	0.0148	CbGeAlD
Irinotecan—Blood creatinine increased—Mesalazine—Crohn's disease	0.000298	0.00542	CcSEcCtD
Irinotecan—Pancreatitis—Azathioprine—Crohn's disease	0.000296	0.00538	CcSEcCtD
Irinotecan—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000291	0.00528	CcSEcCtD
Irinotecan—Oedema—Mercaptopurine—Crohn's disease	0.000288	0.00524	CcSEcCtD
Irinotecan—Cramp muscle—Mesalazine—Crohn's disease	0.000287	0.00521	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000287	0.00521	CcSEcCtD
Irinotecan—CES1—lymph node—Crohn's disease	0.000286	0.0138	CbGeAlD
Irinotecan—ACHE—lymph node—Crohn's disease	0.000286	0.0138	CbGeAlD
Irinotecan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000282	0.00513	CcSEcCtD
Irinotecan—BCHE—mammalian vulva—Crohn's disease	0.00028	0.0135	CbGeAlD
Irinotecan—Abdominal distension—Mesalazine—Crohn's disease	0.000277	0.00503	CcSEcCtD
Irinotecan—Anorexia—Mercaptopurine—Crohn's disease	0.000275	0.00499	CcSEcCtD
Irinotecan—CYP2B6—skin of body—Crohn's disease	0.000274	0.0132	CbGeAlD
Irinotecan—ABCG2—mammalian vulva—Crohn's disease	0.000271	0.0131	CbGeAlD
Irinotecan—Pneumonia—Azathioprine—Crohn's disease	0.000271	0.00492	CcSEcCtD
Irinotecan—Pancreatitis—Mesalazine—Crohn's disease	0.00027	0.0049	CcSEcCtD
Irinotecan—Angina pectoris—Mesalazine—Crohn's disease	0.000268	0.00487	CcSEcCtD
Irinotecan—Neutropenia—Mesalazine—Crohn's disease	0.000257	0.00468	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000256	0.00465	CcSEcCtD
Irinotecan—Decreased appetite—Mercaptopurine—Crohn's disease	0.000251	0.00455	CcSEcCtD
Irinotecan—Weight decreased—Mesalazine—Crohn's disease	0.000249	0.00452	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000249	0.00452	CcSEcCtD
Irinotecan—Pneumonia—Mesalazine—Crohn's disease	0.000247	0.00448	CcSEcCtD
Irinotecan—BCHE—digestive system—Crohn's disease	0.000246	0.0119	CbGeAlD
Irinotecan—Ulcer—Prednisone—Crohn's disease	0.000245	0.00446	CcSEcCtD
Irinotecan—Haemoglobin—Azathioprine—Crohn's disease	0.000243	0.00442	CcSEcCtD
Irinotecan—Haemorrhage—Azathioprine—Crohn's disease	0.000242	0.00439	CcSEcCtD
Irinotecan—Renal failure—Mesalazine—Crohn's disease	0.000241	0.00438	CcSEcCtD
Irinotecan—Jaundice—Mesalazine—Crohn's disease	0.000239	0.00435	CcSEcCtD
Irinotecan—Stomatitis—Mesalazine—Crohn's disease	0.000239	0.00435	CcSEcCtD
Irinotecan—Sweating—Mesalazine—Crohn's disease	0.000235	0.00427	CcSEcCtD
Irinotecan—Hiccups—Prednisone—Crohn's disease	0.000232	0.00422	CcSEcCtD
Irinotecan—Body temperature increased—Mercaptopurine—Crohn's disease	0.000228	0.00414	CcSEcCtD
Irinotecan—CYP2B6—lymphoid tissue—Crohn's disease	0.000222	0.0107	CbGeAlD
Irinotecan—Haemoglobin—Mesalazine—Crohn's disease	0.000221	0.00402	CcSEcCtD
Irinotecan—Rhinitis—Mesalazine—Crohn's disease	0.000221	0.00401	CcSEcCtD
Irinotecan—CYP3A5—digestive system—Crohn's disease	0.000221	0.0106	CbGeAlD
Irinotecan—Haemorrhage—Mesalazine—Crohn's disease	0.00022	0.004	CcSEcCtD
Irinotecan—CYP2B6—digestive system—Crohn's disease	0.000219	0.0106	CbGeAlD
Irinotecan—Immune system disorder—Azathioprine—Crohn's disease	0.000218	0.00397	CcSEcCtD
Irinotecan—Mediastinal disorder—Azathioprine—Crohn's disease	0.000218	0.00396	CcSEcCtD
Irinotecan—Chills—Azathioprine—Crohn's disease	0.000217	0.00394	CcSEcCtD
Irinotecan—Connective tissue disorder—Mesalazine—Crohn's disease	0.000216	0.00393	CcSEcCtD
Irinotecan—Arrhythmia—Azathioprine—Crohn's disease	0.000216	0.00393	CcSEcCtD
Irinotecan—Alopecia—Azathioprine—Crohn's disease	0.000214	0.00388	CcSEcCtD
Irinotecan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000212	0.00386	CcSEcCtD
Irinotecan—Cardiac disorder—Mesalazine—Crohn's disease	0.000204	0.00371	CcSEcCtD
Irinotecan—Sepsis—Prednisone—Crohn's disease	0.000201	0.00366	CcSEcCtD
Irinotecan—Angiopathy—Mesalazine—Crohn's disease	0.0002	0.00363	CcSEcCtD
Irinotecan—Immune system disorder—Mesalazine—Crohn's disease	0.000199	0.00362	CcSEcCtD
Irinotecan—ALB—lymph node—Crohn's disease	0.000199	0.00959	CbGeAlD
Irinotecan—Mediastinal disorder—Mesalazine—Crohn's disease	0.000198	0.00361	CcSEcCtD
Irinotecan—SLC22A3—lymph node—Crohn's disease	0.000198	0.00957	CbGeAlD
Irinotecan—Chills—Mesalazine—Crohn's disease	0.000198	0.00359	CcSEcCtD
Irinotecan—Diarrhoea—Mercaptopurine—Crohn's disease	0.000197	0.00358	CcSEcCtD
Irinotecan—Ill-defined disorder—Azathioprine—Crohn's disease	0.000195	0.00355	CcSEcCtD
Irinotecan—Alopecia—Mesalazine—Crohn's disease	0.000195	0.00354	CcSEcCtD
Irinotecan—Thrombophlebitis—Prednisone—Crohn's disease	0.000195	0.00354	CcSEcCtD
Irinotecan—Anaemia—Azathioprine—Crohn's disease	0.000194	0.00354	CcSEcCtD
Irinotecan—Malaise—Azathioprine—Crohn's disease	0.00019	0.00345	CcSEcCtD
Irinotecan—Flatulence—Mesalazine—Crohn's disease	0.000189	0.00343	CcSEcCtD
Irinotecan—Leukopenia—Azathioprine—Crohn's disease	0.000188	0.00342	CcSEcCtD
Irinotecan—ABCC2—lymph node—Crohn's disease	0.000186	0.00898	CbGeAlD
Irinotecan—Back pain—Mesalazine—Crohn's disease	0.000185	0.00337	CcSEcCtD
Irinotecan—Muscle spasms—Mesalazine—Crohn's disease	0.000184	0.00335	CcSEcCtD
Irinotecan—Vomiting—Mercaptopurine—Crohn's disease	0.000183	0.00333	CcSEcCtD
Irinotecan—Injury—Prednisone—Crohn's disease	0.000183	0.00333	CcSEcCtD
Irinotecan—Rash—Mercaptopurine—Crohn's disease	0.000182	0.0033	CcSEcCtD
Irinotecan—Dermatitis—Mercaptopurine—Crohn's disease	0.000182	0.0033	CcSEcCtD
Irinotecan—Ill-defined disorder—Mesalazine—Crohn's disease	0.000178	0.00323	CcSEcCtD
Irinotecan—Anaemia—Mesalazine—Crohn's disease	0.000177	0.00322	CcSEcCtD
Irinotecan—Discomfort—Azathioprine—Crohn's disease	0.000177	0.00322	CcSEcCtD
Irinotecan—Malaise—Mesalazine—Crohn's disease	0.000173	0.00314	CcSEcCtD
Irinotecan—Vertigo—Mesalazine—Crohn's disease	0.000172	0.00313	CcSEcCtD
Irinotecan—Syncope—Mesalazine—Crohn's disease	0.000172	0.00312	CcSEcCtD
Irinotecan—Leukopenia—Mesalazine—Crohn's disease	0.000172	0.00312	CcSEcCtD
Irinotecan—Nausea—Mercaptopurine—Crohn's disease	0.000171	0.00311	CcSEcCtD
Irinotecan—Infection—Azathioprine—Crohn's disease	0.000171	0.0031	CcSEcCtD
Irinotecan—Loss of consciousness—Mesalazine—Crohn's disease	0.000168	0.00306	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000168	0.00306	CcSEcCtD
Irinotecan—Osteoarthritis—Prednisone—Crohn's disease	0.000168	0.00306	CcSEcCtD
Irinotecan—Thrombocytopenia—Azathioprine—Crohn's disease	0.000168	0.00306	CcSEcCtD
Irinotecan—Cough—Mesalazine—Crohn's disease	0.000167	0.00304	CcSEcCtD
Irinotecan—CYP3A4—digestive system—Crohn's disease	0.000165	0.00799	CbGeAlD
Irinotecan—Hypertension—Mesalazine—Crohn's disease	0.000165	0.00301	CcSEcCtD
Irinotecan—ABCC1—lymph node—Crohn's disease	0.000164	0.00791	CbGeAlD
Irinotecan—Discomfort—Mesalazine—Crohn's disease	0.000161	0.00293	CcSEcCtD
Irinotecan—Hypotension—Azathioprine—Crohn's disease	0.00016	0.00292	CcSEcCtD
Irinotecan—Cardiac arrest—Prednisone—Crohn's disease	0.00016	0.00291	CcSEcCtD
Irinotecan—Confusional state—Mesalazine—Crohn's disease	0.000158	0.00287	CcSEcCtD
Irinotecan—Oedema—Mesalazine—Crohn's disease	0.000156	0.00284	CcSEcCtD
Irinotecan—Anaphylactic shock—Mesalazine—Crohn's disease	0.000156	0.00284	CcSEcCtD
Irinotecan—Infection—Mesalazine—Crohn's disease	0.000155	0.00283	CcSEcCtD
Irinotecan—ABCB1—epithelium—Crohn's disease	0.000154	0.00743	CbGeAlD
Irinotecan—Shock—Mesalazine—Crohn's disease	0.000154	0.0028	CcSEcCtD
Irinotecan—Nervous system disorder—Mesalazine—Crohn's disease	0.000153	0.00279	CcSEcCtD
Irinotecan—Hypokalaemia—Prednisone—Crohn's disease	0.000153	0.00279	CcSEcCtD
Irinotecan—Thrombocytopenia—Mesalazine—Crohn's disease	0.000153	0.00278	CcSEcCtD
Irinotecan—Hyperhidrosis—Mesalazine—Crohn's disease	0.000151	0.00275	CcSEcCtD
Irinotecan—Anorexia—Mesalazine—Crohn's disease	0.000149	0.00271	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000148	0.0027	CcSEcCtD
Irinotecan—Abdominal distension—Prednisone—Crohn's disease	0.000147	0.00266	CcSEcCtD
Irinotecan—Hypotension—Mesalazine—Crohn's disease	0.000146	0.00266	CcSEcCtD
Irinotecan—Pancreatitis—Prednisone—Crohn's disease	0.000143	0.00259	CcSEcCtD
Irinotecan—Sweating increased—Prednisone—Crohn's disease	0.000142	0.00258	CcSEcCtD
Irinotecan—Feeling abnormal—Azathioprine—Crohn's disease	0.000142	0.00257	CcSEcCtD
Irinotecan—Insomnia—Mesalazine—Crohn's disease	0.000141	0.00257	CcSEcCtD
Irinotecan—Paraesthesia—Mesalazine—Crohn's disease	0.00014	0.00255	CcSEcCtD
Irinotecan—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00014	0.00255	CcSEcCtD
Irinotecan—BCHE—lymph node—Crohn's disease	0.00014	0.00678	CbGeAlD
Irinotecan—Dyspnoea—Mesalazine—Crohn's disease	0.000139	0.00254	CcSEcCtD
Irinotecan—Somnolence—Mesalazine—Crohn's disease	0.000139	0.00253	CcSEcCtD
Irinotecan—Dyspepsia—Mesalazine—Crohn's disease	0.000138	0.0025	CcSEcCtD
Irinotecan—Neutropenia—Prednisone—Crohn's disease	0.000136	0.00247	CcSEcCtD
Irinotecan—Decreased appetite—Mesalazine—Crohn's disease	0.000136	0.00247	CcSEcCtD
Irinotecan—Abdominal pain—Azathioprine—Crohn's disease	0.000136	0.00247	CcSEcCtD
Irinotecan—Body temperature increased—Azathioprine—Crohn's disease	0.000136	0.00247	CcSEcCtD
Irinotecan—ABCG2—lymph node—Crohn's disease	0.000136	0.00655	CbGeAlD
Irinotecan—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000135	0.00246	CcSEcCtD
Irinotecan—Fatigue—Mesalazine—Crohn's disease	0.000135	0.00245	CcSEcCtD
Irinotecan—Constipation—Mesalazine—Crohn's disease	0.000134	0.00243	CcSEcCtD
Irinotecan—Pain—Mesalazine—Crohn's disease	0.000134	0.00243	CcSEcCtD
Irinotecan—ABCB1—mammalian vulva—Crohn's disease	0.000134	0.00645	CbGeAlD
Irinotecan—Weight decreased—Prednisone—Crohn's disease	0.000132	0.00239	CcSEcCtD
Irinotecan—Feeling abnormal—Mesalazine—Crohn's disease	0.000129	0.00234	CcSEcCtD
Irinotecan—Acute coronary syndrome—Prednisone—Crohn's disease	0.000128	0.00233	CcSEcCtD
Irinotecan—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000128	0.00233	CcSEcCtD
Irinotecan—Myocardial infarction—Prednisone—Crohn's disease	0.000127	0.00231	CcSEcCtD
Irinotecan—Hypersensitivity—Azathioprine—Crohn's disease	0.000127	0.0023	CcSEcCtD
Irinotecan—Abdominal pain—Mesalazine—Crohn's disease	0.000124	0.00225	CcSEcCtD
Irinotecan—Body temperature increased—Mesalazine—Crohn's disease	0.000124	0.00225	CcSEcCtD
Irinotecan—Bradycardia—Prednisone—Crohn's disease	0.000119	0.00216	CcSEcCtD
Irinotecan—ABCB1—lymphoid tissue—Crohn's disease	0.000119	0.00573	CbGeAlD
Irinotecan—Diarrhoea—Azathioprine—Crohn's disease	0.000118	0.00214	CcSEcCtD
Irinotecan—ABCB1—digestive system—Crohn's disease	0.000117	0.00566	CbGeAlD
Irinotecan—Haemoglobin—Prednisone—Crohn's disease	0.000117	0.00213	CcSEcCtD
Irinotecan—Haemorrhage—Prednisone—Crohn's disease	0.000117	0.00212	CcSEcCtD
Irinotecan—Hypersensitivity—Mesalazine—Crohn's disease	0.000115	0.0021	CcSEcCtD
Irinotecan—Connective tissue disorder—Prednisone—Crohn's disease	0.000114	0.00208	CcSEcCtD
Irinotecan—Dizziness—Azathioprine—Crohn's disease	0.000114	0.00206	CcSEcCtD
Irinotecan—Asthenia—Mesalazine—Crohn's disease	0.000112	0.00204	CcSEcCtD
Irinotecan—Vomiting—Azathioprine—Crohn's disease	0.000109	0.00198	CcSEcCtD
Irinotecan—Rash—Azathioprine—Crohn's disease	0.000108	0.00197	CcSEcCtD
Irinotecan—Dermatitis—Azathioprine—Crohn's disease	0.000108	0.00197	CcSEcCtD
Irinotecan—Flushing—Prednisone—Crohn's disease	0.000108	0.00197	CcSEcCtD
Irinotecan—Headache—Azathioprine—Crohn's disease	0.000108	0.00196	CcSEcCtD
Irinotecan—Diarrhoea—Mesalazine—Crohn's disease	0.000107	0.00195	CcSEcCtD
Irinotecan—Angiopathy—Prednisone—Crohn's disease	0.000106	0.00192	CcSEcCtD
Irinotecan—Immune system disorder—Prednisone—Crohn's disease	0.000105	0.00191	CcSEcCtD
Irinotecan—Arrhythmia—Prednisone—Crohn's disease	0.000104	0.00189	CcSEcCtD
Irinotecan—Dizziness—Mesalazine—Crohn's disease	0.000103	0.00188	CcSEcCtD
Irinotecan—Alopecia—Prednisone—Crohn's disease	0.000103	0.00187	CcSEcCtD
Irinotecan—Nausea—Azathioprine—Crohn's disease	0.000102	0.00185	CcSEcCtD
Irinotecan—Vomiting—Mesalazine—Crohn's disease	9.95e-05	0.00181	CcSEcCtD
Irinotecan—Rash—Mesalazine—Crohn's disease	9.86e-05	0.00179	CcSEcCtD
Irinotecan—Dermatitis—Mesalazine—Crohn's disease	9.85e-05	0.00179	CcSEcCtD
Irinotecan—Headache—Mesalazine—Crohn's disease	9.8e-05	0.00178	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisone—Crohn's disease	9.41e-05	0.00171	CcSEcCtD
Irinotecan—Anaemia—Prednisone—Crohn's disease	9.37e-05	0.0017	CcSEcCtD
Irinotecan—Nausea—Mesalazine—Crohn's disease	9.29e-05	0.00169	CcSEcCtD
Irinotecan—Malaise—Prednisone—Crohn's disease	9.15e-05	0.00166	CcSEcCtD
Irinotecan—Vertigo—Prednisone—Crohn's disease	9.11e-05	0.00166	CcSEcCtD
Irinotecan—Syncope—Prednisone—Crohn's disease	9.09e-05	0.00165	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisone—Crohn's disease	8.91e-05	0.00162	CcSEcCtD
Irinotecan—Hypertension—Prednisone—Crohn's disease	8.76e-05	0.00159	CcSEcCtD
Irinotecan—Discomfort—Prednisone—Crohn's disease	8.53e-05	0.00155	CcSEcCtD
Irinotecan—Oedema—Prednisone—Crohn's disease	8.28e-05	0.0015	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—Crohn's disease	8.28e-05	0.0015	CcSEcCtD
Irinotecan—Infection—Prednisone—Crohn's disease	8.22e-05	0.00149	CcSEcCtD
Irinotecan—Shock—Prednisone—Crohn's disease	8.14e-05	0.00148	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—Crohn's disease	8.12e-05	0.00148	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—Crohn's disease	8e-05	0.00145	CcSEcCtD
Irinotecan—Anorexia—Prednisone—Crohn's disease	7.89e-05	0.00143	CcSEcCtD
Irinotecan—Insomnia—Prednisone—Crohn's disease	7.49e-05	0.00136	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—Crohn's disease	7.43e-05	0.00135	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—Crohn's disease	7.29e-05	0.00132	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—Crohn's disease	7.2e-05	0.00131	CcSEcCtD
Irinotecan—Fatigue—Prednisone—Crohn's disease	7.14e-05	0.0013	CcSEcCtD
Irinotecan—Constipation—Prednisone—Crohn's disease	7.08e-05	0.00129	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—Crohn's disease	6.82e-05	0.00124	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—Crohn's disease	6.77e-05	0.00123	CcSEcCtD
Irinotecan—ABCB1—lymph node—Crohn's disease	6.69e-05	0.00323	CbGeAlD
Irinotecan—Body temperature increased—Prednisone—Crohn's disease	6.54e-05	0.00119	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—Crohn's disease	6.54e-05	0.00119	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—Crohn's disease	6.1e-05	0.00111	CcSEcCtD
Irinotecan—Asthenia—Prednisone—Crohn's disease	5.94e-05	0.00108	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—Crohn's disease	5.66e-05	0.00103	CcSEcCtD
Irinotecan—Dizziness—Prednisone—Crohn's disease	5.47e-05	0.000995	CcSEcCtD
Irinotecan—Vomiting—Prednisone—Crohn's disease	5.26e-05	0.000957	CcSEcCtD
Irinotecan—Rash—Prednisone—Crohn's disease	5.22e-05	0.000949	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—Crohn's disease	5.21e-05	0.000948	CcSEcCtD
Irinotecan—Headache—Prednisone—Crohn's disease	5.19e-05	0.000943	CcSEcCtD
Irinotecan—Nausea—Prednisone—Crohn's disease	4.92e-05	0.000894	CcSEcCtD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	4.3e-05	0.0031	CbGpPWpGaD
Irinotecan—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.17e-05	0.003	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—IFNG—Crohn's disease	4.16e-05	0.003	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	4.08e-05	0.00294	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.01e-05	0.00289	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.01e-05	0.00289	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.9e-05	0.00281	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—CXCL8—Crohn's disease	3.87e-05	0.00279	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.8e-05	0.00274	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	3.78e-05	0.00272	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.7e-05	0.00267	CbGpPWpGaD
Irinotecan—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	3.67e-05	0.00264	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL17A—Crohn's disease	3.59e-05	0.00258	CbGpPWpGaD
Irinotecan—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	3.58e-05	0.00258	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.57e-05	0.00257	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.52e-05	0.00253	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.48e-05	0.00251	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—IL6—Crohn's disease	3.45e-05	0.00248	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.39e-05	0.00244	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	3.36e-05	0.00242	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL12B—Crohn's disease	3.33e-05	0.0024	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	3.32e-05	0.00239	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.32e-05	0.00239	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.15e-05	0.00227	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.12e-05	0.00225	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.12e-05	0.00225	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	3.08e-05	0.00222	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	3.08e-05	0.00222	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	3.05e-05	0.0022	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.03e-05	0.00219	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.96e-05	0.00213	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.92e-05	0.0021	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.92e-05	0.0021	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.89e-05	0.00208	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.89e-05	0.00208	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.88e-05	0.00208	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.82e-05	0.00203	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.74e-05	0.00198	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.74e-05	0.00198	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	2.71e-05	0.00195	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—CRP—Crohn's disease	2.7e-05	0.00195	CbGpPWpGaD
Irinotecan—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	2.67e-05	0.00193	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	2.59e-05	0.00187	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.58e-05	0.00186	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.54e-05	0.00183	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.54e-05	0.00183	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.5e-05	0.0018	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—ICAM1—Crohn's disease	2.48e-05	0.00179	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.45e-05	0.00177	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL10—Crohn's disease	2.44e-05	0.00176	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.42e-05	0.00174	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.36e-05	0.0017	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	2.32e-05	0.00167	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.31e-05	0.00166	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.3e-05	0.00165	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.25e-05	0.00162	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.21e-05	0.0016	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	2.21e-05	0.00159	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	2.17e-05	0.00157	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—IL6—Crohn's disease	2.17e-05	0.00157	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.17e-05	0.00157	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.16e-05	0.00156	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	2.15e-05	0.00155	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.1e-05	0.00152	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	2.07e-05	0.00149	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.06e-05	0.00148	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.03e-05	0.00146	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.97e-05	0.00142	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.94e-05	0.0014	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.93e-05	0.00139	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.92e-05	0.00138	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IFNG—Crohn's disease	1.89e-05	0.00136	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—MTMR3—Crohn's disease	1.88e-05	0.00135	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.82e-05	0.00131	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.8e-05	0.0013	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.79e-05	0.00129	CbGpPWpGaD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.77e-05	0.00127	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PLA2G4F—Crohn's disease	1.74e-05	0.00125	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.71e-05	0.00123	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL1B—Crohn's disease	1.69e-05	0.00121	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.67e-05	0.0012	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RSPO3—Crohn's disease	1.66e-05	0.0012	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PLA2G4F—Crohn's disease	1.65e-05	0.00119	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	1.65e-05	0.00119	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.65e-05	0.00119	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PLA2G4F—Crohn's disease	1.59e-05	0.00115	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.58e-05	0.00114	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SEL1L—Crohn's disease	1.57e-05	0.00113	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.57e-05	0.00113	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.57e-05	0.00113	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.56e-05	0.00112	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	1.55e-05	0.00112	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PLA2G4F—Crohn's disease	1.55e-05	0.00112	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.53e-05	0.0011	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	1.51e-05	0.00109	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	1.5e-05	0.00108	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	1.5e-05	0.00108	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	1.5e-05	0.00108	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—MTMR3—Crohn's disease	1.48e-05	0.00106	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—FADS1—Crohn's disease	1.46e-05	0.00105	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.44e-05	0.00104	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IFNG—Crohn's disease	1.43e-05	0.00103	CbGpPWpGaD
Irinotecan—ABCC1—Disease—LTF—Crohn's disease	1.41e-05	0.00102	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—MTMR3—Crohn's disease	1.4e-05	0.00101	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—MTMR3—Crohn's disease	1.4e-05	0.00101	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PLA2G4F—Crohn's disease	1.4e-05	0.00101	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	1.39e-05	0.000999	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.37e-05	0.000989	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.37e-05	0.000989	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GPX4—Crohn's disease	1.37e-05	0.000986	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—MTMR3—Crohn's disease	1.35e-05	0.000974	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.34e-05	0.000965	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—F5—Crohn's disease	1.34e-05	0.000963	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	1.33e-05	0.000961	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GCKR—Crohn's disease	1.32e-05	0.000953	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—MTMR3—Crohn's disease	1.32e-05	0.00095	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—MTMR3—Crohn's disease	1.28e-05	0.000925	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.28e-05	0.000925	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—IL1B—Crohn's disease	1.28e-05	0.000921	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TNF—Crohn's disease	1.22e-05	0.000881	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.21e-05	0.000874	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.21e-05	0.000872	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.2e-05	0.000866	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—MTMR3—Crohn's disease	1.19e-05	0.000857	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—MTMR3—Crohn's disease	1.18e-05	0.000849	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—FADS1—Crohn's disease	1.15e-05	0.000829	CbGpPWpGaD
Irinotecan—ABCC1—Disease—GCKR—Crohn's disease	1.14e-05	0.000819	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.1e-05	0.000795	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—FADS1—Crohn's disease	1.09e-05	0.000787	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—FADS1—Crohn's disease	1.09e-05	0.000787	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.09e-05	0.000785	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GPX4—Crohn's disease	1.08e-05	0.000776	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—FADS1—Crohn's disease	1.05e-05	0.000759	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.05e-05	0.000758	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GCKR—Crohn's disease	1.04e-05	0.00075	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—FADS1—Crohn's disease	1.03e-05	0.00074	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	1.03e-05	0.000739	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GPX4—Crohn's disease	1.02e-05	0.000737	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GPX4—Crohn's disease	1.02e-05	0.000737	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SLC11A1—Crohn's disease	1.01e-05	0.000724	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	1e-05	0.000722	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—FADS1—Crohn's disease	1e-05	0.000721	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GCKR—Crohn's disease	9.87e-06	0.000712	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GCKR—Crohn's disease	9.87e-06	0.000712	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL6—Crohn's disease	9.87e-06	0.000711	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GPX4—Crohn's disease	9.86e-06	0.00071	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.76e-06	0.000703	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	9.71e-06	0.0007	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.67e-06	0.000697	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GPX4—Crohn's disease	9.61e-06	0.000693	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GCKR—Crohn's disease	9.52e-06	0.000686	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GPX4—Crohn's disease	9.37e-06	0.000675	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GCKR—Crohn's disease	9.28e-06	0.000669	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TNF—Crohn's disease	9.28e-06	0.000669	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—FADS1—Crohn's disease	9.26e-06	0.000668	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—FADS1—Crohn's disease	9.18e-06	0.000662	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GCKR—Crohn's disease	9.05e-06	0.000652	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	8.98e-06	0.000647	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTMR3—Crohn's disease	8.72e-06	0.000628	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GPX4—Crohn's disease	8.67e-06	0.000625	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PLA2G4F—Crohn's disease	8.63e-06	0.000622	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RBX1—Crohn's disease	8.62e-06	0.000621	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HSPA1B—Crohn's disease	8.62e-06	0.000621	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GPX4—Crohn's disease	8.6e-06	0.00062	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.55e-06	0.000616	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTMR3—Crohn's disease	8.52e-06	0.000614	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GCKR—Crohn's disease	8.38e-06	0.000604	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GCKR—Crohn's disease	8.3e-06	0.000598	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—ITGA4—Crohn's disease	8.22e-06	0.000592	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL3—Crohn's disease	8.01e-06	0.000577	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	7.84e-06	0.000565	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RASGRP1—Crohn's disease	7.75e-06	0.000558	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PLA2G4F—Crohn's disease	7.56e-06	0.000545	CbGpPWpGaD
Irinotecan—ABCC1—Disease—UBE2D1—Crohn's disease	7.56e-06	0.000544	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.44e-06	0.000536	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTMR3—Crohn's disease	7.34e-06	0.000529	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	7.32e-06	0.000527	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.06e-06	0.000509	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.8e-06	0.00049	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—FADS1—Crohn's disease	6.79e-06	0.000489	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	6.78e-06	0.000489	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—FADS1—Crohn's disease	6.64e-06	0.000478	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.63e-06	0.000478	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	6.55e-06	0.000472	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.51e-06	0.000469	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.47e-06	0.000466	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.47e-06	0.000466	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTMR3—Crohn's disease	6.43e-06	0.000463	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPX4—Crohn's disease	6.36e-06	0.000458	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPX4—Crohn's disease	6.22e-06	0.000448	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.17e-06	0.000445	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.15e-06	0.000443	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GCKR—Crohn's disease	6.14e-06	0.000443	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GCKR—Crohn's disease	6e-06	0.000433	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.95e-06	0.000429	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.8e-06	0.000418	CbGpPWpGaD
Irinotecan—ALB—Metabolism—FADS1—Crohn's disease	5.72e-06	0.000412	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	5.69e-06	0.00041	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.66e-06	0.000408	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2RA—Crohn's disease	5.61e-06	0.000405	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CXCL8—Crohn's disease	5.45e-06	0.000393	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SMAD3—Crohn's disease	5.41e-06	0.00039	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPX4—Crohn's disease	5.35e-06	0.000386	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GCKR—Crohn's disease	5.17e-06	0.000373	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—FADS1—Crohn's disease	5.01e-06	0.000361	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	4.86e-06	0.000351	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPX4—Crohn's disease	4.69e-06	0.000338	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	4.66e-06	0.000336	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.58e-06	0.00033	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GCKR—Crohn's disease	4.53e-06	0.000326	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ALB—Crohn's disease	4.21e-06	0.000303	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTMR3—Crohn's disease	3.96e-06	0.000285	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—JAK2—Crohn's disease	3.77e-06	0.000272	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—Crohn's disease	3.68e-06	0.000265	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TYK2—Crohn's disease	3.53e-06	0.000254	CbGpPWpGaD
Irinotecan—ABCC1—Disease—JAK2—Crohn's disease	3.36e-06	0.000242	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—Crohn's disease	3.31e-06	0.000239	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.23e-06	0.000233	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD4—Crohn's disease	3.19e-06	0.00023	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—Crohn's disease	3.17e-06	0.000228	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—Crohn's disease	3.14e-06	0.000226	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—Crohn's disease	3.14e-06	0.000226	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FADS1—Crohn's disease	3.09e-06	0.000222	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.08e-06	0.000222	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—Crohn's disease	3.03e-06	0.000218	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—Crohn's disease	2.95e-06	0.000213	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—Crohn's disease	2.9e-06	0.000209	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX4—Crohn's disease	2.89e-06	0.000208	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—Crohn's disease	2.88e-06	0.000208	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GCKR—Crohn's disease	2.79e-06	0.000201	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—Crohn's disease	2.75e-06	0.000198	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—Crohn's disease	2.75e-06	0.000198	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—Crohn's disease	2.67e-06	0.000192	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—Crohn's disease	2.65e-06	0.000191	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—Crohn's disease	2.64e-06	0.00019	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—Crohn's disease	2.58e-06	0.000186	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—Crohn's disease	2.52e-06	0.000182	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—Crohn's disease	2.47e-06	0.000178	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—Crohn's disease	2.33e-06	0.000168	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—Crohn's disease	2.31e-06	0.000167	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—Crohn's disease	1.95e-06	0.000141	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—Crohn's disease	1.91e-06	0.000138	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—Crohn's disease	1.72e-06	0.000124	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—Crohn's disease	1.71e-06	0.000123	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.67e-06	0.00012	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—Crohn's disease	1.44e-06	0.000104	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—Crohn's disease	1.44e-06	0.000104	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—Crohn's disease	1.26e-06	9.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—Crohn's disease	8.88e-07	6.4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—Crohn's disease	7.77e-07	5.6e-05	CbGpPWpGaD
